OpenAIs Potential IPO Valuation Trends and Key Risks to Watch New York Fed Study Shows Surging Gas Prices Disproportionately Impact LowerIncome Households Nigel Farage Under Pressure to Substantiate Russian Hack Claim Over Cryptocurrency Gift US Prioritizes American AI Integration in Asia Following TrumpXi Talks Block Expands Square Partnership Network Ecosystem Growth Signals Potential Upside Summer Electric Bills Surge as Rising Temperatures and Power Costs Raise Concerns SNFCA Q4 2025 Earnings EPS of 053 Highlights Profitability Amidst Steady Operations City Holding Company CHCO Q1 2026 Earnings Narrow EPS Beat Supports Modest Stock Gain MASI Q1 2026 Earnings EPS Falls 26 Short of Estimates as Margins Come Under Pressure BioRestorative Therapies Inc BRTX Q1 2026 Earnings Narrower Loss Surprises Stock Rises 78 BridgeBio Oncology Therapeutics Inc BBOT Q1 2026 Earnings NarrowerThanExpected Loss Fails to Stem Stock Slide BTSGU Q1 2026 Earnings EPS Surpasses Estimates by 23 Stock Flat amid Strong Operational Performance Consumer Portfolio Services CPSS Slides Marginally as Uptrend Support Test Looms Resideo Technologies REZI Gains 114 as Stock Approaches Key Resistance Lipocine Inc LPCN Shows Resilience Breaking Down the 226 Rally Lisata Therapeutics LSTA Holds Steady at 314 as RangeBound Trading Persists Amazon AMZN Slips 08 as Consolidation Holds Near 266 Level Huawei Unveils New Chip Design Approach Plans Fall Launch for Smartphone Chips Amid US Restrictions VNDA Q1 2026 Earnings WiderThanExpected Loss Raises Concerns Owens Corning OC Gains 163 as Stock Holds Above Key Support Level MDT Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Deutsche Bank Q1 2026 Earnings Modest EPS Beat Amid Mixed Market Sentiment Guidewire Software GWRE Q1 2026 Earnings Strong EPS Beat Drives Positive Market Sentiment Acadia Healthcare Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick VSTS Q1 2026 Earnings Massive EPS Beat Drives Investor Scrutiny Amid Revenue Discretion BNB Plus Corp BNBX Q3 2025 Earnings Narrowed Loss Beats Expectations as Cost Controls Take Effect West Pharmaceutical Services WST Q1 2026 Earnings Strong EPS Surprise of 258 Outpaces Estimates